ÂÜÀòÂÒÂ×

Mick Hurrey has extensive experience in pharmaceutical development, with roles ranging from Scientist I to Vice President in various companies such as Revagenix, InCarda Therapeutics, SteadyMed Therapeutics, Gilead Sciences, and Vertex Pharmaceuticals. Mick has a Ph.D. in Analytical Chemistry from the University of North Carolina at Chapel Hill and a B.S. in Chemistry from the University of Central Florida. Responsibilities have included leading CMC activities, product development, managing labs, and serving as a subject matter expert in physical chemistry.